LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Covalent Therapies Biomea Fusion specializes in developing innovative covalent small molecules for genetically defined cancers and metabolic diseases, offering potential advantages over conventional drugs. This unique approach presents a sales opportunity for targeting healthcare providers seeking advanced therapies for specific patient populations.

Recent Regulatory Approvals With recent Health Canada clearance for their lead product BMF-219 in treating type 1 diabetes, Biomea Fusion has demonstrated regulatory progress. Sales teams can capitalize on this achievement to engage with healthcare institutions and professionals looking for cutting-edge treatments with approved clinical trial applications.

Strategic Leadership Recruitment The appointment of Juan Pablo Frías, M.D. as Chief Medical Officer signals a focus on bolstering the company's medical expertise. Sales representatives can leverage Dr. Frías' industry reputation to establish credibility and forge connections with key opinion leaders and decision-makers in the healthcare sector.

Financial Stability and Funding With a revenue range between $10M - $50M and a funding of $150M, Biomea Fusion showcases financial stability and growth potential. This financial profile can be leveraged by sales teams to attract investors, establish partnerships, and build confidence with potential clients seeking long-term collaborations.

Expansion into Obesity Treatment The development of a GLP-1 receptor agonist by Biomea Fusion for obesity treatment represents a strategic expansion into new therapeutic areas. Sales professionals can explore this diversification opportunity to engage with stakeholders in the obesity treatment market and broaden the company's product reach.

Similar companies to Biomea Fusion

Biomea Fusion Tech Stack

Biomea Fusion uses 8 technology products and services including WordPress, Underscore.js, Popper, and more. Explore Biomea Fusion's tech stack below.

  • WordPress
    Content Management System
  • Underscore.js
    Javascript Libraries
  • Popper
    Miscellaneous
  • Elementor
    Page Builders
  • Lua
    Programming Languages
  • Yoast SEO Premium
    Search Engines
  • Limit Login Attempts Reloaded
    Web Platform Extensions
  • IIS
    Web Servers

Media & News

Biomea Fusion's Email Address Formats

Biomea Fusion uses at least 1 format(s):
Biomea Fusion Email FormatsExamplePercentage
FLast@biomeafusion.comJDoe@biomeafusion.com
59%
Last@biomeafusion.comDoe@biomeafusion.com
30%
FL@biomeafusion.comJD@biomeafusion.com
9%
First.Last@biomeafusion.comJohn.Doe@biomeafusion.com
2%

Frequently Asked Questions

Where is Biomea Fusion's headquarters located?

Minus sign iconPlus sign icon
Biomea Fusion's main headquarters is located at 900 Middlefield Rd 4th Floor Downtown Redwood City, California 94063 US. The company has employees across 2 continents, including North AmericaEurope.

What is Biomea Fusion's stock symbol?

Minus sign iconPlus sign icon
Biomea Fusion is a publicly traded company; the company's stock symbol is BMEA.

What is Biomea Fusion's official website and social media links?

Minus sign iconPlus sign icon
Biomea Fusion's official website is biomeafusion.com and has social profiles on LinkedIn.

How much revenue does Biomea Fusion generate?

Minus sign iconPlus sign icon
As of September 2024, Biomea Fusion's annual revenue reached $15M.

What is Biomea Fusion's SIC code NAICS code?

Minus sign iconPlus sign icon
Biomea Fusion's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Biomea Fusion have currently?

Minus sign iconPlus sign icon
As of September 2024, Biomea Fusion has approximately 105 employees across 2 continents, including North AmericaEurope. Key team members include Chief People Officer: N. C.Chief Operational Officer: H. T.Chief Medical Officer, Head Of Diabetes: J. P. F.. Explore Biomea Fusion's employee directory with LeadIQ.

What industry does Biomea Fusion belong to?

Minus sign iconPlus sign icon
Biomea Fusion operates in the Biotechnology Research industry.

What technology does Biomea Fusion use?

Minus sign iconPlus sign icon
Biomea Fusion's tech stack includes WordPressUnderscore.jsPopperElementorLuaYoast SEO PremiumLimit Login Attempts ReloadedIIS.

What is Biomea Fusion's email format?

Minus sign iconPlus sign icon
Biomea Fusion's email format typically follows the pattern of . Find more Biomea Fusion email formats with LeadIQ.

How much funding has Biomea Fusion raised to date?

Minus sign iconPlus sign icon
As of September 2024, Biomea Fusion has raised $150M in funding. The last funding round occurred on Mar 29, 2023 for $150M.

When was Biomea Fusion founded?

Minus sign iconPlus sign icon
Biomea Fusion was founded in 2017.
Biomea Fusion

Biomea Fusion

Biotechnology ResearchCalifornia, United States51-200 Employees

We are a biopharmaceutical company focused on the discovery and development of covalent small molecules to treat patients with genetically defined cancers and metabolic diseases. A covalent small molecule is a synthetic compound that forms a permanent bond to its target protein and offers a number of potential advantages over conventional non-covalent drugs including greater target selectivity, lower drug exposure and the ability to drive a deeper, more durable response.
Leveraging our extensive expertise in covalent binding chemistry and development, we built our proprietary FUSION™ System platform to advance a pipeline of novel covalent therapies. Our lead product candidate, BMF-219, is an orally bioavailable, potent and selective covalent inhibitor of MENIN, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. Beyond BMF-219, we are utilizing our novel platform to develop covalent treatments against other high-value oncogenic drivers of cancer. Our goal is to utilize our capabilities and platform to become a leader in developing covalent small molecules in order to maximize the depth and durability of clinical benefit when treating various cancers.
The name biomea derives from the Greek word bios, meaning “life,” and the Latin word mea, meaning “my.”
At Biomea Fusion, we develop medicines to improve the life of the individual.

Section iconCompany Overview

Headquarters
900 Middlefield Rd 4th Floor Downtown Redwood City, California 94063 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
BMEA
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $150M

    Biomea Fusion has raised a total of $150M of funding over 2 rounds. Their latest funding round was raised on Mar 29, 2023 in the amount of $150M.

  • $10M$50M

    Biomea Fusion's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $150M

    Biomea Fusion has raised a total of $150M of funding over 2 rounds. Their latest funding round was raised on Mar 29, 2023 in the amount of $150M.

  • $10M$50M

    Biomea Fusion's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.